DUBLIN--(BUSINESS WIRE)--The "Cell Therapy Global Market Report 2022: By Technique, By Therapy, By Application" report has been added to ResearchAndMarkets.com's offering.
The global cell therapy market is expected to grow from $9.02 billion in 2021 to $10.74 billion in 2022 at a compound annual growth rate (CAGR) of 19%. The market is expected to reach $19.75 billion in 2026 at a CAGR of 16.5%.
Major players in the cell therapy market are Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc. and AlloCure.
The cell therapy market consists of sales of cell therapy and related services. Cell therapy (CT) helps repair or replace damaged tissues and cells. A variety of cells are used for the treatment of diseases includes skeletal muscle stem cells, hematopoietic (blood-forming) stem cells (HSC), lymphocytes, mesenchymal stem cells, pancreatic islet cells, and dendritic cells.
The main techniques used in cell therapy are stem cell therapy, cell vaccine, adoptive cell transfer (act), fibroblast cell therapy and chondrocyte cell therapy. Stem cell treatment, also known as regenerative medicine, uses stem cells or their derivatives to stimulate the healing response of sick, defective, or wounded tissue. The different types of therapies include allogeneic therapies, autologous therapies and is used in various applications such as oncology, cardiovascular disease (CVD), orthopedic, wound healing, others.
The rising prevalence of chronic diseases contributed to the growth of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), chronic disease is a condition that lasts for one year or more and requires medical attention or limits daily activities or both and includes heart disease, cancer, diabetes, and Parkinson's disease.
Stem cells can benefit the patients suffering from spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis. For instance, according to the Center for Diseases Control and Prevention report in 2021, due to poor nutrition, and lack of physical activity, 6 in 10 adults in the USA are suffering from a chronic disease and 4 in 10 have two or more diseases.
According to International Diabetes Federation, in 2019, globally 463 million people have diabetes and the number is expected to rise to 700 million by 2045 . According to the Parkinson's Foundation, every year, 60,000 Americans are diagnosed with PD, and more than 10 million people are living with PD worldwide. The growing prevalence of chronic diseases increased the demand for cell therapies and contributed to the growth of the market.
The high cost of cell therapy hindered the growth of the cell therapy market. Cell therapies have become a common choice of treatment in recent years as people are looking for the newest treatment options. Although there is a huge increase in demand for cell therapies, they are still very costly to try. Therefore, the high cost of cell therapy restraints the growth of the cell therapy market.
Key players in the market are strategically partnering and collaborating to expand the product portfolio and geographical presence of the company.
Key Topics Covered:
1. Executive Summary
2. Cell Therapy Market Characteristics
3. Cell Therapy Market Trends And Strategies
4. Impact Of COVID-19 On Cell Therapy
5. Cell Therapy Market Size And Growth
5.1. Global Cell Therapy Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Cell Therapy Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Cell Therapy Market Segmentation
6.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Stem Cell Therapy
- Cell Vaccine
- Adoptive Cell Transfer (ACT)
- Fibroblast Cell Therapy
- Chondrocyte Cell Therapy
6.2. Global Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Allogeneic Therapies
- Autologous Therapies
6.3. Global Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Oncology
- Cardiovascular Disease (CVD)
- Orthopedic
- Wound Healing
- Others
7. Cell Therapy Market Regional And Country Analysis
7.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Companies Mentioned
- Fibrocell Science Inc.
- JCR Pharmaceuticals Co. Ltd.
- PHARMICELL Co. Ltd.
- Osiris Therapeutics inc.
- MEDIPOST
- Vericel Corporation
- Anterogen Co. Ltd.
- Kolon TissueGene inc.
- Stemedica Cell Technologies Inc.
- AlloCure
- Arteriocyte Medical Systems
- Athersys inc.
- Baxter Healthcare Corporation
- Bone Therapeutics
- Celgene Corporation
- Cell Medica
- Cellerant Therapeutics
- Forticell Bioscience
- Mesoblast Ltd.
- AlloSource
- Holostem Terapie Avanzate S.r.l
- Pharmicell Co. Ltd.
- TiGenix (Takeda Pharmaceuticals)
- Stempeutics Research Pvt. Ltd.
- Nipro Corp.
- Tego Science
- Corestem inc.
- Forticell Bioscience
- Cellerant Therapeutics
- Cells for Cells
For more information about this report visit https://www.researchandmarkets.com/r/x8usr1
